Zometa may eventually be tested against other cancers that tend to spread to bones.
This study was presented at an American Society of Clinical Oncology conference in Chicago this past weekend.
Treatment reduces risk of breast cancer return
CHICAGO The drug is called Zometa.
Researchers studied 1,800 pre-menopausal women taking hormone treatments for early stage breast cancer.
Findings show Zometa cut the chance that cancer would recur by one-third.
